A role for CD5 in cognate interactions between T cells and B cells, and identification of a novel ligand for CD5

被引:60
作者
Bikah, G
Lynd, FM
Aruffo, AA
Ledbetter, JA
Bondada, S
机构
[1] Univ Kentucky, Dept Immunol & Microbiol, Lexington, KY 40536 USA
[2] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA
[3] Bristol Myers Squibb Pharmaceut Res Inst, Seattle, WA 98121 USA
关键词
CD5; T cell; B cell;
D O I
10.1093/intimm/10.8.1185
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD5 is a glycoprotein expressed at a high level on the surface of mature T lymphocytes. Studies with CD5 mAb and CD5-deficient mice have shown that the CD5 molecules have a significant role in T cell growth response. However, the precise role of CD5 in immune cell interactions is still unclear. The present study provides evidence that CD5 plays a direct role in providing growth signals during the contact-dependent activation and proliferation of splenic a cells. An anti-CDS mAb inhibited T(h)1- and T(h)2-type cell-induced a cell proliferation. CD5-Ig, a chimeric fusion protein, induced proliferation of resting a cells. Flow cytometric analyses using CD5-Ig and mAb to CD72 demonstrated that CD5 bound to a ligand (CD5L), and this binding was not blocked by a variety of anti-CD72 mAb, Also, CD5-Ig did not bind to CD72(+)-transfected cells. Immunoprecipitation of surface labeled a cell molecules with CD5-Ig showed that CD5L was composed of 77-80 and 38-40 kDa polypeptide chains, distinct from CD72, CD5L was expressed on activated splenic a cells, but not T cells, whereas its expression was constitutive on peritoneal a cells and on a lymphoma cell lines.
引用
收藏
页码:1185 / 1196
页数:12
相关论文
共 49 条
  • [1] ALBEROLAILA J, 1992, J IMMUNOL, V148, P1287
  • [2] MOLECULAR AND BIOLOGICAL CHARACTERIZATION OF A MURINE LIGAND FOR CD40
    ARMITAGE, RJ
    FANSLOW, WC
    STROCKBINE, L
    SATO, TA
    CLIFFORD, KN
    MACDUFF, BM
    ANDERSON, DM
    GIMPEL, SD
    DAVISSMITH, T
    MALISZEWSKI, CR
    CLARK, EA
    SMITH, CA
    GRABSTEIN, KH
    COSMAN, D
    SPRIGGS, MK
    [J]. NATURE, 1992, 357 (6373) : 80 - 82
  • [3] THE CD40 LIGAND, GP39, IS DEFECTIVE IN ACTIVATED T-CELLS FROM PATIENTS WITH X-LINKED HYPER-IGM SYNDROME
    ARUFFO, A
    FARRINGTON, M
    HOLLENBAUGH, D
    LI, X
    MILATOVICH, A
    NONOYAMA, S
    BAJORATH, J
    GROSMAIRE, LS
    STENKAMP, R
    NEUBAUER, M
    ROBERTS, RL
    NOELLE, RJ
    LEDBETTER, JA
    FRANCKE, U
    OCHS, HD
    [J]. CELL, 1993, 72 (02) : 291 - 300
  • [4] MULTIPLE ACTIN GENES ENCODING THE SAME ALPHA-MUSCLE ISOFORM ARE EXPRESSED DURING ASCIDIAN DEVELOPMENT
    BEACH, RL
    JEFFERY, WR
    [J]. DEVELOPMENTAL BIOLOGY, 1992, 151 (01) : 55 - 66
  • [5] Identification of a novel inducible cell-surface ligand of CD5 on activated lymphocytes
    Biancone, L
    Bowen, MA
    Lim, A
    Aruffo, A
    Andres, G
    Stamenkovic, I
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (03) : 811 - 819
  • [6] CD5-mediated negative regulation of antigen receptor-induced growth signals in B-1 B cells
    Bikah, G
    Carey, J
    Ciallella, JR
    Tarakhovsky, A
    Bondada, S
    [J]. SCIENCE, 1996, 274 (5294) : 1906 - 1909
  • [7] BIKAH G, 1995, 9 INT C IMM
  • [8] CD5 ACTS AS A TYROSINE KINASE SUBSTRATE WITHIN A RECEPTOR COMPLEX COMPRISING T-CELL RECEPTOR ZETA-CHAIN CD3 AND PROTEIN-TYROSINE KINASES P56LCK AND P59FYN
    BURGESS, KE
    YAMAMOTO, M
    PRASAD, KVS
    RUDD, CE
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (19) : 9311 - 9315
  • [9] CAMBIER JC, 1994, ANNU REV IMMUNOL, V12, P457, DOI 10.1146/annurev.immunol.12.1.457
  • [10] CAMBIER JC, 1987, ANNU REV IMMUNOL, V5, P175, DOI 10.1146/annurev.immunol.5.1.175